Grant

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Open

The NIH SBIR Phase IIB Strategic Breakthrough Award offers grant funding for US small business concerns to bridge the gap between Phase II and commercialization for later-stage R&D. Applicants must have previously received an NIH SBIR or STTR Phase II award.

See your fit

Key facts

Organiser
National Institutes of Health
Deadline
April 5, 2029
Opens
May 28, 2026
Amount
Grant
Open to
United States
Sectors
Any sector

3 details are locked

See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.

See your fit

Key questions about NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Who can apply to NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)?

Eligible locations: United States. The company must be incorporated in United States. Other requirements: Must have previously received an NIH SBIR or STTR Phase II award; Only one NIH Phase IIB award allowed per project; Submitted within first six due dates after budget expiration.

When is the NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) deadline?

The NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) deadline is April 5, 2029. Applications opened on May 28, 2026.

See more grants in United States

Other programs in this category

Verified on September 28, 2026 against the official page.